Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 5, 2026 · Leadership change · Financial statements
AbCellera Biologics Inc.
9
Leadership change
Jun 5, 2026
| Item 5.02 | Director or executive officer departure or appointment |
| Item 9.01 | Financial statements and exhibits |
AbCellera Biologics Inc. filed this to disclose a change in directors or executive officers: appointments, departures, or role changes that can signal a strategic shift.
150 W 4th Ave Vancouver, BC V5Y 1G6 T 1. Victor Sandor to its Board of Directors 2026-06-05 VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced the appointment of Victor Sandor, M.
This filing reports Item 5.02 (director or executive officer departure or appointment). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
AbCellera Biologics Inc. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
